Related Experiment Video
Updated: Oct 7, 2025
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Impact of General Factors on Glioma Immunotherapy
Qilin Huang1, Dongmei Wang2, Guojie Yao3
1Department of Neurosurgery, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, China.
Abstract:
Glioma remains the most common malignant tumor in the brain and is also the most difficult to treat. Immunotherapy achieving long-lasting tumor remission in multiple cancer types has received considerable attention due to its potential to improve the treatment outcomes of patients with glioma. However, clinical trials have not yet demonstrated major improvements in prognoses, which might be attributable to the extrinsic components and intrinsic mechanisms involved in the tumor microenvironment and immune system. It is particularly noteworthy that there is emerging evidence that current routine treatment modalities and the physical and psychological characteristics of patients have different impacts on the efficacy of glioma immunotherapy. This article addresses how these factors interact with the host immune system and tumor microenvironment, and highlights their potential roles in glioma immunotherapy, with the ultimate goal of developing better immunotherapy-based personalized medicine strategies.
Insights
Glioma immunotherapy shows promise but faces challenges due to the tumor microenvironment and patient factors. Understanding these interactions is key to developing effective, personalized glioma treatments.
Area of Science:
- Neuro-oncology
- Cancer Immunology
- Personalized Medicine
Background:
- Glioma is the most common and difficult-to-treat malignant brain tumor.
- Immunotherapy offers potential for long-lasting remission in various cancers, including glioma.
- Current glioma immunotherapies have limited success, possibly due to tumor microenvironment and immune system complexities.
Purpose of the Study:
- To explore the impact of tumor microenvironment and patient-specific factors on glioma immunotherapy efficacy.
- To elucidate the interplay between host immunity, tumor microenvironment, and treatment outcomes.
- To identify strategies for developing improved, personalized glioma immunotherapy.
Main Methods:
- Review of current literature on glioma immunotherapy.
- Analysis of extrinsic and intrinsic factors influencing treatment response.
- Investigation of patient characteristics and their role in immunotherapy effectiveness.
Main Results:
- The tumor microenvironment presents significant barriers to effective glioma immunotherapy.
- Patient-specific factors, including physical and psychological characteristics, modulate immunotherapy outcomes.
- Routine treatments may also influence the efficacy of novel immunotherapies.
Conclusions:
- Addressing the complexities of the tumor microenvironment and patient factors is crucial for advancing glioma immunotherapy.
- Personalized medicine approaches are essential for optimizing treatment strategies.
- Further research is needed to overcome current limitations and improve patient prognoses in glioma treatment.
